Diabetes is heterogeneous.
We measure why.
The first at-home rapid fingerstick test for insulin and glucose, paired with a clinical decision support system for metabolic phenotyping.
The market is measuring
the wrong thing.
One hormone. Five phenotypes.
Glucose tells you that diabetes exists. Insulin tells you why. The same HbA1c can reflect five completely different metabolic phenotypes — each requiring a different clinical response. Without insulin data, physicians are guessing.
A test, a decision engine, a workflow
From a single drop of blood to a clinical decision — inside the care infrastructure physicians already use.
Fingerstick Strip
Insulin + glucose from ~20 µL whole blood. No wearable. No lab. No specialty equipment.
CDSS
Classifies each patient into a metabolic phenotype. Generates actionable guidance per result.
RPM Integration
Fits into existing Remote Patient Monitoring workflows. No new billing infrastructure required.
Interested in the
technology?
We're working with clinicians, researchers, and industry partners.
Connect on LinkedIn